Vanda Pharmaceuticals News
Most Popular Vanda Pharmaceuticals Story
Vanda stock skyrockets after surprising FDA approval
After watching Vanda Pharmaceuticals' stock slide into the cellar in recent months, investors sent its shares into orbit after hearing that the FDA had approved its new drug for schizophrenia.... Read more...
Latest Headlines
- October 16, 2009
- October 13, 2009
- July 23, 2009
- February 25, 2009
- October 31, 2008
- July 28, 2008
- June 26, 2008
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
